Even though these ILC2s with T cell recruitment signatures do not show significant expression of Ifng, their receptor Ifnγr1 is up-regulated in majority of the cells, suggesting that cells are ready to accept and process the IFN-mediated signals via paracrine interactions in the tumour-modified microenvironment. The gene discussed is IFNA1; the disease is neoplasm.